FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1432031000168104: romosozumab 105 mg / 1.17 mL injection, 1.17 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4302091000168112 romosozumab 105 mg / 1.17 mL injection, 1.17 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4302101000168119 romosozumab 105 mg/1.17 mL injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
romosozumab 105 mg/1.17 mL injection, syringe Is a romosozumab true Inferred relationship Some
romosozumab 105 mg/1.17 mL injection, syringe Is a medicinal product unit of use true Inferred relationship Some
romosozumab 105 mg/1.17 mL injection, syringe has manufactured dose form injection true Inferred relationship Some
romosozumab 105 mg/1.17 mL injection, syringe has unit of use syringe true Inferred relationship Some 393190229
romosozumab 105 mg/1.17 mL injection, syringe has intended active ingredient romosozumab true Inferred relationship Some 557008534
romosozumab 105 mg/1.17 mL injection, syringe has Australian BoSS romosozumab true Inferred relationship Some 557008534
Inbound Relationships Type Active Source Characteristic Refinability Group
Evenity 105 mg/1.17 mL injection, 1.17 mL syringe Is a True romosozumab 105 mg/1.17 mL injection, syringe Inferred relationship Some
romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes has MPUU True romosozumab 105 mg/1.17 mL injection, syringe Inferred relationship Some 756385565

Reference Sets

Medicinal product unit of use reference set

Back to Start